Suppression of progenitor cell growth by vancomycin following autologous stem cell transplantation

Bone Marrow Transplantation

Volumn 19, Issue 10, 1997, Pages 1029-1032

  Meehan, K R ^a   Verma, U N ^a   Esteva Lorenzo, F ^a   Mazumder, A ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Autologous stem cell transplantation; Drug induced neutropenia; Multiple myeloma; Vancomycin

Indexed keywords

VANCOMYCIN;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW SUPPRESSION; CASE REPORT; CELL GROWTH; COLONY FORMING UNIT; CONTROL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYPERSENSITIVITY REACTION; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE MYELOMA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0030919050     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700780     Document Type: Article

References (23)

1. Williams L, Domen RE. Zeta potential and vancomycin-red blood cell intractions. Arch Pathol Lab Med 1990; 114: 1262-1263.
2. Christie DJ, Van Buren N, Lennon SS, Putnam JL. Vancomycin-dependent antibodies associated with thrombocytopenia and refractoriness to platelet transfusion in patients with leukemia. Blood 1990; 75: 518-523.
3. Zenon GJ, Cadle RM, Hamill RJ. Vancomycin-induced thrombocytopenia. Arch Intern Med 1991; 151: 995-996.
4. Weitzman SA, Stosse TP. Drug-induced immunological neutropenia. Lancet 1978; 1: 1068-1071.
5. Adrouny A, Maguerditchian S, Koo CH et al. Agranulocytosis related to vancomycin therapy. Am J Med 1986; 81: 1059-1061.
6. Charak BS, Louie R, Malloy BB et al. The effect of amphotericin B, aztreonam, imipenim and cephalosporins on bone marrow progenitor cell activity. J Antimicrob Chemother 1991; 27: 95-104.
7. Mackett RL, Guay DRP. Vancomycin-induced neutropenia. Can Med Assoc J 1985; 132: 39-40.
8. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. New Engl J Med 1993; 328: 1323-1332.
9. Attal M, Schlaifer D, Rubie H et al. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective randomized trial. J Clin Oncol 1991; 9: 865-870.
10. Meehan KR, Verma UN, Rajagopal C et al. Stem cell transplantation with high dose chemoradiotherapy and interleukin-2. J Infus Chemother 1995; 6: 28-32.
11. Meehan KR, Rajagopal C, Cahill R et al. The induction of autologus graft-versus-host disease by IL-2 in patients with hematologic malignancies. Am Soc Blood Bone Marrow Transplant 1995; 1: 94a (Abstr. 508).
12. Meehan KR, Verma UN, Rajagopal C et al. Interleukin-2 activated peripheral blood stem cell transplantation for breast cancer: clinical and biological correlates. Bone Marrow Transplant 1996 (submitted).
13. Teitelbaum AH, Bell AJ, Brown SL. Filgrastim (r-metHuG-CSF) reversal of drug-induced agranulocytosis. Am J Med 1993; 95: 245-246.
14. Verma UN, Areman E, Dickerson SA et al. Interleukin-2 activation of chemotherapy and growth factor mobilized peripheral blood stem cells for the generation of cytotoxic effectors. Bone Marrow Transplant 1995; 15: 199-204.
15. Areman EM, Mazumder A, Kotula PL et al. Hematopoietic potential of IL-2 cultured peripheral blood stem cells from breast cancer patients. Bone Marrow Transplant 1996; 18: 521-525.
16. Strikas R, Studio J, Venezio FR, O'Keefe JP. Vancomycin-induced neutropenia. J Infect Dis 1982; 146: 575.
17. Kauffman CA, Severence PJ, Silva J, Huard TK. Neutropenia associated with vancomycin therapy. So Med J 1982; 75: 1131-1133.
18. Kesarwala HH, Rahill WJ, Amaram N. Vancomycin induced neutropenia. Lancet 1981; 1: 1423.
19. Shinohara YT, Colbert J. Vancomycin-induced neutropenia during treatment of endocarditis in a pediatric patient. Ann Pharmacother 1994; 28: 723-725.
20. Borland CDR, Farrar WE. Reversible neutropenia from vancomycin. JAMA 1979; 242: 2392-2393.
21. West BC. Vancomycin-induced neutropenia. So Med J 1981; 74: 1255-1256.
22. Biaise D, Olive D, Stoppa AM et al. Hematologic and immunologic effects of recombinant interleukin-2 after bone marrow transplantation. Blood 1990; 76: 1092-1097.
23. Charak BS, Brynes RK, Chogyoji M et al. Graft-versus-leukemia effect on interleukin-2 activated bone marrow: correlation with eradication of residual disease. Transplant 1993; 56: 31-37.